Validation Results for BHM® COVID-19 Antigen Rapid Test Shows up to 98.34% Accuracy in Lab Testing

AsiaIn Vitro Diagnostic Testing
Written By Guest User

Birmingham Biotech’s BHM® COVID-19 Antigen Rapid Test achieved positive validation results at the local lab in Thailand.

The evaluation showed that the tested device was able to detect SARS-CoV-2 antigen in the tested nasal swab samples with 96.67% sensitivity and 100% specificity.

The evaluation showed that the tested device was able to detect SARS-CoV-2 antigen in the tested saliva samples with 95.00% sensitivity and 100% specificity.

Guest User
Previous

In Vitro Diagnostic Test Distribution in Ukraine with GoodMed
Next

BHM® IVD PRODUCTS RECEIVE CE MARKING